Transport of nanocarriers across gastrointestinal epithelial cells by a new transcellular route induced by targeting ICAM-1

Journal of Controlled Release

Volumn 163, Issue 1, 2012, Pages 25-33

  Ghaffarian, Rasa ^a   Bhowmick, Tridib ^b   Muro, Silvia ^a,b  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

Enzyme delivery; Gastrointestinal epithelium; ICAM 1; Polymer nanocarriers; Trancytosis transport

Indexed keywords

ENZYME DELIVERY; GASTROINTESTINAL EPITHELIUM; ICAM-1; NANOCARRIERS; TRANCYTOSIS TRANSPORT;

BIOCHEMISTRY; CELLS; DRUG DELIVERY; ELECTRON MICROSCOPY; ENZYMES; MOLECULAR BIOLOGY; MONOLAYERS; POLYMERS; TISSUE;

CELL CULTURE;

ALPHA GALACTOSIDASE; CELL SURFACE MARKER; INTERCELLULAR ADHESION MOLECULE 1; NANOCARRIER; POLYMER; RADIOISOTOPE;

CELL CULTURE; CELL MEMBRANE PERMEABILITY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TRANSPORT; ELECTRON MICROSCOPY; ENDOCYTOSIS; FABRY DISEASE; FLUORESCENCE MICROSCOPY; GASTROINTESTINAL TRACT; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; MONOLAYER CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; STOMACH EPITHELIUM; TRANSCELLULAR CELL MIGRATION; TRANSCYTOSIS;

ALPHA-GALACTOSIDASE; BIOLOGICAL TRANSPORT; CACO-2 CELLS; DRUG CARRIERS; GASTROINTESTINAL TRACT; HUMANS; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE-1; NANOSTRUCTURES; POLYSTYRENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84866739807     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.06.007     Document Type: Conference Paper

References (54)

1. F. Gabor, C. Fillafer, L. Neutsch, G. Ratzinger, and M. Wirth Improving oral delivery Handb. Exp. Pharmacol. 197 2010 345 398
2. V. Torchilin Multifunctional and stimuli-sensitive pharmaceutical nanocarriers Eur. J. Pharm. Biopharm. 71 3 2009 431 444
3. D. Pan, S.D. Carauthers, J. Chen, P.M. Winter, A. SenPan, A.H. Schmieder, S.A. Wickline, and G.M. Lanza Nanomedicine strategies for molecular targets with MRI and optical imaging Future Med. Chem. 2 3 2010 471 490
4. A. des Rieux, V. Fievez, M. Garinot, Y.J. Schneider, and V. Preat Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach J. Control. Release 116 1 2006 1 27
5. Z. Cai, Y. Wang, L.J. Zhu, and Z.Q. Liu Nanocarriers: a general strategy for enhancement of oral bioavailability of poorly absorbed or pre-systemically metabolized drugs Curr. Drug Metab. 11 2 2010 197 207
6. A. Lamprecht, H. Yamamoto, H. Takeuchi, and Y. Kawashima Nanoparticles enhance therapeutic efficiency by selectively increased local drug dose in experimental colitis in rats J. Pharmacol. Exp. Ther. 315 1 2005 196 202
7. L. Serra, J. Domenech, and N.A. Peppas Engineering design and molecular dynamics of mucoadhesive drug delivery systems as targeting agents Eur. J. Pharm. Biopharm. 71 3 2009 519 528
8. J.H. Hamman, P.H. Demana, and E.I. Olivier Targeting receptors, transporters and site of absorption to improve oral drug delivery Drug Target Insights 2 2007 71 81
9. N. Mishra, S. Tiwari, B. Vaidya, G.P. Agrawal, and S.P. Vyas Lectin anchored PLGA nanoparticles for oral mucosal immunization against hepatitis B J. Drug Target. 19 1 2010 67 78
10. L.M. Bareford, and P.W. Swaan Endocytic mechanisms for targeted drug delivery Adv. Drug Deliv. Rev. 59 8 2007 748 758
11. P.L. Tuma, and A.L. Hubbard Transcytosis: crossing cellular barriers Physiol. Rev. 83 3 2003 871 932
12. M.A. Deli Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery Biochim. Biophys. Acta 1788 4 2009 892 910
13. N.N. Salama, A. Fasano, M. Thakar, and N.D. Eddington The impact of DeltaG on the oral bioavailability of low bioavailable therapeutic agents J. Pharmacol. Exp. Ther. 312 1 2005 199 205
14. M. El-Sayed, M. Ginski, C. Rhodes, and H. Ghandehari Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers J. Control. Release 81 3 2002 355 365
15. S. Muro W.C. Aird, Endothelial Biomedicine 2007 Cambridge University Press New York 1058 1070
16. S.D. Marlin, and T.A. Springer Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1) Cell 51 5 1987 813 819
17. C. Garnacho, R. Dhami, E. Simone, T. Dziubla, J. Leferovich, E.H. Schuchman, V. Muzykantov, and S. Muro Delivery of acid sphingomyelinase in normal and Niemann-Pick disease mice using intercellular adhesion molecule-1-targeted polymer nanocarriers J. Pharmacol. Exp. Ther. 325 2 2008 400 408
18. S. Muro, C. Garnacho, J.A. Champion, J. Leferovich, C. Gajewski, E.H. Schuchman, S. Mitragotri, and V.R. Muzykantov Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers Mol. Ther. 16 8 2008 1450 1458
19. S. Muro, T. Dziubla, W. Qiu, J. Leferovich, X. Cui, E. Berk, and V.R. Muzykantov Endothelial targeting of high-affinity multivalent polymer nanocarriers directed to intercellular adhesion molecule 1 J. Pharmacol. Exp. Ther. 317 3 2006 1161 1169
20. T. Zimmerman, and F.J. Blanco Inhibitors targeting the LFA-1/ICAM-1 cell-adhesion interaction: design and mechanism of action Curr. Pharm. Des. 14 22 2008 2128 2139
21. F.S. Villanueva, R.J. Jankowski, S. Klibanov, M.L. Pina, S.M. Alber, S.C. Watkins, G.H. Brandenburger, and W.R. Wagner Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells Circulation 98 1 1998 1 5
22. C.E. Haug, R.B. Colvin, F.L. Delmonico, H. Auchincloss Jr., N. Tolkoff-Rubin, F.I. Preffer, R. Rothlein, S. Norris, L. Scharschmidt, and A.B. Cosimi A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients Transplantation 55 4 1993 766 772 (discussion 772-773)
23. S. Muro, R. Wiewrodt, A. Thomas, L. Koniaris, S.M. Albelda, V.R. Muzykantov, and M. Koval A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1 J. Cell Sci. 116 Pt 8 2003 1599 1609
24. O.S. Finikova, A.Y. Lebedev, A. Aprelev, T. Troxler, F. Gao, C. Garnacho, S. Muro, R.M. Hochstrasser, and S.A. Vinogradov Oxygen microscopy by two-photon-excited phosphorescence Chemphyschem 9 12 2008 1673 1679
25. J.C. Murciano, S. Muro, L. Koniaris, M. Christofidou-Solomidou, D.W. Harshaw, S.M. Albelda, D.N. Granger, D.B. Cines, and V.R. Muzykantov ICAM-directed vascular immunotargeting of antithrombotic agents to the endothelial luminal surface Blood 101 10 2003 3977 3984
26. J. Hsu, D. Serrano, T. Bhowmick, K. Kumar, Y. Shen, Y.C. Kuo, C. Garnacho, and S. Muro Enhanced endothelial delivery and biochemical effects of alpha-galactosidase by ICAM-1-targeted nanocarriers for Fabry disease J. Control. Release 149 3 2011 323 331
27. C. Chittasupho, S.X. Xie, A. Baoum, T. Yakovleva, T.J. Siahaan, and C.J. Berkland ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells Eur. J. Pharm. Sci. 37 2 2009 141 150
28. G.E. Weller, F.S. Villanueva, A.L. Klibanov, and W.R. Wagner Modulating targeted adhesion of an ultrasound contrast agent to dysfunctional endothelium Ann. Biomed. Eng. 30 8 2002 1012 1019
29. R. Rossin, S. Muro, M.J. Welch, V.R. Muzykantov, and D.P. Schuster In vivo imaging of 64Cu-labeled polymer nanoparticles targeted to the lung endothelium J. Nucl. Med. 49 1 2008 103 111
30. A.J. Calderon, T. Bhowmick, J. Leferovich, B. Burman, B. Pichette, V. Muzykantov, D.M. Eckmann, and S. Muro Optimizing endothelial targeting by modulating the antibody density and particle concentration of anti-ICAM coated carriers J. Control. Release 150 1 2011 37 44
31. J. Hsu, L. Northrup, T. Bhowmick, and S. Muro Enhanced delivery of alpha-glucosidase for Pompe disease by ICAM-1-targeted nanocarriers: comparative performance of a strategy for three distinct lysosomal storage disorders Nanomedicine 2011 10.1016/j.nano.2011.08.014
32. D. Kaiserlian, D. Rigal, J. Abello, and J.P. Revillard Expression, function and regulation of the intercellular adhesion molecule-1 (ICAM-1) on human intestinal epithelial cell lines Eur. J. Immunol. 21 10 1991 2415 2421
33. I.J. Hidalgo, T.J. Raub, and R.T. Borchardt Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability Gastroenterology 96 3 1989 736 749
34. S. Muro, C. Gajewski, M. Koval, and V.R. Muzykantov ICAM-1 recycling in endothelial cells: a novel pathway for sustained intracellular delivery and prolonged effects of drugs Blood 105 2 2005 650 658
35. S. Skolnik, X. Lin, J. Wang, X.H. Chen, T. He, and B. Zhang Towards prediction of in vivo intestinal absorption using a 96-well Caco-2 assay J. Pharm. Sci. 99 7 2010 3246 3265
36. S. Muro, M. Mateescu, C. Gajewski, M. Robinson, V.R. Muzykantov, and M. Koval Control of intracellular trafficking of ICAM-1-targeted nanocarriers by endothelial Na+/H+ exchanger proteins Am. J. Physiol. Lung Cell. Mol. Physiol. 290 5 2006 L809 L817
37. P.D. Ward, T.K. Tippin, and D.R. Thakker Enhancing paracellular permeability by modulating epithelial tight junctions Pharm. Sci. Technol. Today 3 10 2000 346 358
38. G. Camenisch, J. Alsenz, H. van de Waterbeemd, and G. Folkers Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight Eur. J. Pharm. Sci. 6 4 1998 317 324
39. M.B. Bowen-Yacyshyn, C.F. Bennett, N. Nation, D. Rayner, and B.R. Yacyshyn Amelioration of chronic and spontaneous intestinal inflammation with an antisense oligonucleotide (ISIS 9125) to intracellular adhesion molecule-1 in the HLA-B27/beta2 microglobulin transgenic rat model J. Pharmacol. Exp. Ther. 302 3 2002 908 917
40. A.M. Hopkins, A.W. Baird, and A. Nusrat ICAM-1: targeted docking for exogenous as well as endogenous ligands Adv. Drug Deliv. Rev. 56 6 2004 763 778
41. B. Vainer Intercellular adhesion molecule-1 (ICAM-1) in ulcerative colitis: presence, visualization, and significance APMIS 118 Suppl. 129 2010 1 43
42. Z.Y. Huang, D.R. Barreda, R.G. Worth, Z.K. Indik, M.K. Kim, P. Chien, and A.D. Schreiber Differential kinase requirements in human and mouse Fc-gamma receptor phagocytosis and endocytosis J. Leukoc. Biol. 80 6 2006 1553 1562
43. S. Muro, and V. Muzykantov V. Weissig, G.G.M. D'Souza, Organelle-specific pharmaceutical nanotechnology 2010 John Wiley & Sons Hoboken, NJ 449 474
44. A. Fahr, and X. Liu Drug delivery strategies for poorly water-soluble drugs Expert Opin. Drug Deliv. 4 4 2007 403 416
45. C. Damge, C.P. Reis, and P. Maincent Nanoparticle strategies for the oral delivery of insulin Expert Opin. Drug Deliv. 5 1 2008 45 68
46. R.J. Desnick, Y.A. Ioannou, and C.M. Eng C. Scriver, A. Beaudet, W. Sly, D. Valle, B. Childs, K. Kinzler, B. Vogelstein, The Metabolic and Molecular Bases of Inherited Disease 2001 McGraw-Hill 3733 3747
47. K. Park, I.C. Kwon, and K. Park Oral protein delivery: current status and future prospect React. Funct. Polym. 71 3 2011 280 287
48. N. Kamei, M. Morishita, H. Chiba, N.J. Kavimandan, N.A. Peppas, and K. Takayama Complexation hydrogels for intestinal delivery of interferon beta and calcitonin J. Control. Release 134 2 2009 98 102
49. M. Sharma, V. Sharma, A.K. Panda, and D.K. Majumdar Development of enteric submicron particle formulation of papain for oral delivery Int. J. Nanomedicine 6 2011 2097 2111
50. S.K. Lai, Y.Y. Wang, and J. Hanes Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues Adv. Drug Deliv. Rev. 61 2 2009 158 171
51. V. Mane, and S. Muro Biodistribution and endocytosis of ICAM-1-targeting antibodies and nanocarriers in the gastrointestinal tract in mice. Int. J. Nanomedicine 7 2012 4223 4237
52. C. Prego, D. Torres, and M.J. Alonso The potential of chitosan for the oral administration of peptides Expert Opin. Drug Deliv. 2 5 2005 843 854
53. S.K. Lai, D.E. O'Hanlon, S. Harrold, S.T. Man, Y.Y. Wang, R. Cone, and J. Hanes Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus Proc. Natl. Acad. Sci. U. S. A. 104 5 2007 1482 1487
54. S. Mura, H. Hillaireau, J. Nicolas, S. Kerdine-Romer, B. Le Droumaguet, C. Delomenie, V. Nicolas, M. Pallardy, N. Tsapis, and E. Fattal Biodegradable nanoparticles meet the bronchial airway barrier: how surface properties affect their interaction with mucus and epithelial cells Biomacromolecules 12 11 2011 4136 4143